VVOS
Vivos Therapeutics, Inc. [VVOS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VVOS Stock Summary
Top 10 Correlated ETFs
VVOS
Top 10 Correlated Stocks
VVOS
In the News
VVOS Financial details
Company Rating
-
Market Cap
7.21M
Income
-7.11M
Revenue
13.8M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
114
Optionable
No
Shortable
Yes
Earnings
06 Jun 2024
P/E
-1.01
Forward P/E
-
PEG
-
P/S
0.79
P/B
223.84
P/C
-
P/FCF
-0.88
Quick Ratio
0.17
Current Ratio
0.28
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.87
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-1.61%
EPS Q/Q
32.57%
-
-
-
-
SMA20
-23.79%
SMA50
-27.3%
SMA100
-57.5%
Inst Own
-
Inst Trans
-
ROA
-98%
ROE
-291%
ROC
-6.06%
Gross Margin
60%
Oper. Margin
-132%
Profit Margin
-70%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.4-48.79
52W High
-95.54%
52W Low
+7%
RSI
39.72
Rel Volume
0.77
Avg Volume
219.41K
Volume
169K
Perf Week
-8.55%
Perf Month
-21.61%
Perf Quarter
-52.86%
Perf Half Y
-52.44%
-
-
-
-
Beta
7.903
-
-
Volatility
0.05%, 0.34%
Prev Close
0.47%
Price
2.14
Change
-1.38%
Company Profile
- Volume Average 219.41K
- Market Capitalization 7.21M
- Employee 114
- CEO Mr. R. Kirk Huntsman
- Headquarters Highlands Ranch,CO,US
- IPO Date 2020-12-11
-
Website
https://vivos.com 
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
